Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Cardona

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|January 6, 2010
Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active diseasePere-Joan Cardona
Clinical & Developmental Immunology|March 26, 2011
A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosisPere-Joan Cardona
Archivos De Bronconeumologia|November 7, 2007
[Therapeutic vaccines against tuberculosis: a glowing future]Pere-Joan Cardona
Frontiers in Immunology|May 7, 2026
Reinfection as a central constraint on tuberculosis vaccine developmentPere-Joan Cardona
Frontiers in Microbiology|October 14, 2016
The Progress of Therapeutic Vaccination with Regard to TuberculosisPere-Joan Cardona
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 5, 2017
Pathogenesis of tuberculosis and other mycobacteriosisPere-Joan Cardona
Medicina Clinica|June 24, 2006
[Mycobacterium tuberculosis and Homo sapiens: a long road to cross]Pere-Joan Cardona
Frontiers in Immunology|May 31, 2017
What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan"Pere-Joan Cardona
Inflammation & Allergy Drug Targets|March 14, 2007
New insights on the nature of latent tuberculosis infection and its treatmentPere-Joan Cardona
Frontiers in Immunology|July 1, 2026
Rethinking TYK2 P1104A: a flawed evolutionary trade-off in tuberculosis?Pere-Joan Cardona
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Archivum Immunologiae Et Therapiae Experimentalis|January 6, 2010
Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active diseasePere-Joan Cardona
Clinical & Developmental Immunology|March 26, 2011
A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosisPere-Joan Cardona
Archivos De Bronconeumologia|November 7, 2007
[Therapeutic vaccines against tuberculosis: a glowing future]Pere-Joan Cardona
Frontiers in Immunology|May 7, 2026
Reinfection as a central constraint on tuberculosis vaccine developmentPere-Joan Cardona
Frontiers in Microbiology|October 14, 2016
The Progress of Therapeutic Vaccination with Regard to TuberculosisPere-Joan Cardona
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 5, 2017
Pathogenesis of tuberculosis and other mycobacteriosisPere-Joan Cardona
Medicina Clinica|June 24, 2006
[Mycobacterium tuberculosis and Homo sapiens: a long road to cross]Pere-Joan Cardona
Frontiers in Immunology|May 31, 2017
What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan"Pere-Joan Cardona
Inflammation & Allergy Drug Targets|March 14, 2007
New insights on the nature of latent tuberculosis infection and its treatmentPere-Joan Cardona
Frontiers in Immunology|July 1, 2026
Rethinking TYK2 P1104A: a flawed evolutionary trade-off in tuberculosis?Pere-Joan Cardona
Pageof 14